The TWAS reported an association between genetically predicted TERT gene expression levels and risk of both GBM and non-GBM, which is in line with our finding that the TERT gene variant is associated with risk of glioma, regardless of IDH mutation status. Here, IDH1 is linked to central nervous system cancer.